NIH-funded research R01 grant

Understanding how certain immune structures help fight cancer

Official title: ROLES AND MECHANISMS OF TERTIARY LYMPHOID STRUCTURES IN ANTI-TUMOR IMMUNITY

Funded at Ohio State University · NIH-11005311 · Data updated 2026-11-12

This study is looking at how certain immune structures in tumors can help the body fight pancreatic cancer better, and it aims to find ways to improve treatment for patients by understanding how these structures work.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startJanuary 1, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$425,880
NIH project number5R01CA286017-02
Project IDNIH-11005311 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with pancreatic ductal adenocarcinoma who are undergoing surgical resection.

Less likely to help

Patients with early-stage pancreatic cancer who do not exhibit the formation of tertiary lymphoid structures may not benefit from this research.

What this research studies

This research investigates the role of tertiary lymphoid structures (TLS) in enhancing the immune response against pancreatic cancer. By examining how these structures form in tumors and their impact on T cell immunity, the study aims to uncover mechanisms that could improve patient outcomes. The researchers will analyze both human and mouse models to determine how TLS contribute to the development of specific T cell types that are crucial for effective anti-tumor immunity. This could lead to new strategies for boosting the immune response in cancer patients.

Why it matters

Potential benefit: If successful, this research could lead to improved cancer treatments that enhance the body's immune response against tumors.

How similar studies have gone: Other research has shown promising results regarding the role of tertiary lymphoid structures in cancer immunity, indicating that this approach has potential for significant findings.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Gunderson, Andrew — Ohio State University
  • Study coordinator: Gunderson, Andrew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.